Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system.

Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation: Molecular Therapy - Oncolytics

Disrupting the Interplay between Programmed Cell Death Protein 1 and Programmed Death Ligand 1 with Spherical Nucleic Acids in Treating Cancer

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity: Molecular Therapy

National Cancer Institute on Instagram: One of the most important findings in cancer research in the past two decades is that tumors can create force-field-like protection against the immune system. A new

JCM, Free Full-Text

Genes, Free Full-Text

Transgenic viral expression of PH-20, IL-12, and sPD1-Fc enhances immune cell infiltration and anti-tumor efficacy of an oncolytic virus: Molecular Therapy - Oncolytics

IJMS, Free Full-Text

Cancers, Free Full-Text

Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme - Ahmed - 2023 - MedComm – Oncology - Wiley Online Library

Frontiers Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma

The Antiviral Apparatus: STING and Oncolytic Virus Restriction: Molecular Therapy - Oncolytics

Frontiers HDAC inhibitors enhance the anti-tumor effect of immunotherapies in hepatocellular carcinoma

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic - Zou - 2023 - Global Challenges - Wiley Online Library